Results 201 to 210 of about 10,644 (242)

Genetic Defects in Thyroid Hormone Supply. [PDF]

open access: yes, 2018
Gianfranco Fenzi   +2 more
core  

Data from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>

open access: gold
Martin L. Read   +19 more
openalex   +1 more source
Some of the next articles are maybe not open access.

Related searches:

The Sodium-Iodide Symporter

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, 2004
The sodium-iodide symporter (NIS) is an intrinsic plasma membrane protein that mediates active transport of iodide in the thyroid gland and several other extra-thyroidal tissues. This activity has been utilized for many years for imaging the thyroid gland and for treatment of thyroid disease both benign and malignant.
C H, Baker, J C, Morris
openaire   +2 more sources

Sodium/iodide symporter in thyroid cancer

Experimental and Clinical Endocrinology & Diabetes, 2001
[No abstract available]
C. Mian   +5 more
openaire   +4 more sources

Sodium Iodide Symporter in Health and Disease

Thyroid, 2001
Radioiodine-concentrating activity in thyroid tissues has allowed the use of radioiodine as a diagnostic and therapeutic agent for patients with thyroid disorders such as well-differentiated thyroid cancer. However, some extrathyroidal tissues also take up radioiodine, contributing to unwanted side effects of radioiodine therapy.
D H, Shen   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy